Knabl, Julia
Hüttenbrenner, Rebecca
Mahner, Sven
Kainer, Franz
Desoye, Gernot
Jeschke, Udo
Funding for this research was provided by:
Universitätsklinikum Augsburg
Article History
Accepted: 29 October 2022
First Online: 20 December 2022
Declarations
:
: JK, RH, FK, GD and UJ have no competing interests to declare. SM: Research funding, advisory board, honorary or travel expenses: AbbVie, AstraZeneca, Clovis, Eisai, GlaxoSmithKline, Hubro, Medac, MSD, Novartis, Nykode, Olympus, PharmaMar, Pfizer, Roche, Sensor Kinesis, Teva, Tesaro.